MRKNYSELive delayed
$130.76
-0.31-0.24%
SourceCNBCAs ofJul 27, 2026, 8:10 PM
Delayed market data from CNBC. Not investment advice.
Merck is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for MRK · Finnhub.
- Market cap
- $324.99B
- P/E (TTM)
- 17.80
- EPS (TTM)
- $3.5542
- Div. yield
- 2.59%
- 52-week range
- $76.66 – $131.74
- Volume
- —
- Avg volume
- 8.83M
Price history
OHLC candles for MRK · 3mo · 1d · Yahoo Finance · delayed · EMA / RSI
+18.84%periodDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
DirectHigh impactGlobalMostly neutralGoogle News
Merck (MRK) Is Up 5.4% After Expanding HIV PrEP Access And Launching Oral Cholesterol DrugMerck (MRK) Is Up 5.4% After Expanding HIV PrEP Access And Launching Oral Cholesterol Drug Yahoo FinanceBroad market headline — check whether risk appetite shifts.
Watch: MRK · HIV · .SPX · .FTSE
DirectHigh impactGoogle News
(MRK) and the Role of Price-Sensitive AllocationsDirectHigh impactGoogle News
Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health NarrativeDirectHigh impactGoogle News
Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?DirectHigh impactGoogle News
Merck (MRK) Declines More Than Market: Some Information for InvestorsDirectHigh impactGoogle News
MRK Stock Jumps on FDA Nod for Cholesterol-Lowering PillDirectHigh impactGoogle News
Why Merck & Co. (MRK) Stock Is Up TodayDirectHigh impactGoogle News
Merck (MRK) Stock Sees Modest Fair Value Lift As Analysts Raise Targets